Description
Docaravimab Biosimilar - Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III mAb - Research Grade
Target
Rabies Virus Strain ERA GP Ectodomain Epitope G-III
Target Alias Name
Docaravimab/DOCARAVIMAB [INN]/DOCARAVIMAB [WHO-DD]/IMMUNOGLOBULIN G2/ ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN/ DIMER IMMUNOGLOBULIN G2B/ ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL 62-71-3 .GAMMA.2B-CHAIN)/ DISULFIDE WITH MUS MUSCULUS MONOCLONAL 62-71-3 .KAPPA.-CHAIN/ DIMER IMMUNOGLOBULIN G2B-KAPPA/ ANTI-(RABIES VIRUS STRAINERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-III)/ MUS MUSCULUS MONOCLONAL ANTIBODY/Rabies Virus Strain ERA GP Ectodomain Epitope G-III/anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-III
Isotype/Mimetic
IgG2b/Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression